April 22, 2026
Carlsbad, California, April 22, 2026 — Rapalogix Health, a biotechnology company advancing a science-first approach to cellular longevity and skin health, today announced the appointment of Angela Hildebrand as Chief Commercial Officer. Hildebrand will own the enterprise commercial strategy and multi-year business planning for Rapalogix, scaling the company’s go-to-market operations as RLX-201 and Re-Q Pro-Longevity Face Serum expand across professional and consumer channels.
Hildebrand is a growth-stage commercial leader with more than 20 years of experience scaling revenue and architecting enterprise commercial operating models across healthcare, professional, and prestige retail channels. Prior to joining Rapalogix, she served as Chief Commercial Officer at Nutrafol, developing strategies to accelerate both professional and retail channels. Her career also includes a distinguished decade at L’Oréal, where she served as General Manager for SkinCeuticals. During her tenure, she led all business functions, re-accelerated growth through disciplined investment reallocation, and scaled the U.S. commercial organization to its leadership position as the #1 medical skincare brand recommended by physicians. Earlier in her career, Hildebrand held high-impact leadership roles at Obagi Medical Products, where she managed national sales through critical post-acquisition transitions, following foundational industry experience at Pfizer.
As CCO, Hildebrand will direct the operations that deliver growth across all commercial channels, overseeing sales, marketing, and commercial operations. She will lead the commercialization of RLX-201 across dermatology and medical aesthetics channels and help shape the company’s broader consumer strategy. Her appointment follows a period of significant scientific and industry recognition for Rapalogix Health, including awards at IMCAS Paris, Octane’s Aesthetics Tech Forum, the INNOCOS Beauty, Tech & Longevity Summit, and AMWC Monaco.
“Angela is one of the most respected commercial leaders in our industry, with a rare combination of strategic depth and operational rigor across both professional and consumer channels,” said Rahul Mehta, PhD, CEO and Co-Founder of Rapalogix Health. “Her track record of building category-defining brands and high-performing commercial teams makes her the ideal leader to scale Rapalogix at this inflection point. With RLX-201 gaining momentum and our pipeline advancing, Angela will be instrumental in translating our scientific platform into sustained commercial leadership.”
"Rapalogix Health is building something genuinely new in skin health, grounded in rigorous longevity science and a product platform with real clinical differentiation," said Angela Hildebrand, Chief Commercial Officer of Rapalogix Health. "I am excited by the opportunity to partner with Rahul and the team to scale this platform with the same discipline and ambition that defines category leaders. The demand from physicians and patients is clear, and my top priority is building the field organization to meet it and ensure this technology reaches everyone who can benefit from it."
Hildebrand holds an M.B.A. in Management and a Bachelor of Science in Psychology/Biology from Palm Beach Atlantic University, with additional executive development from MIT and the CMR Institute.
About Rapalogix Health
Rapalogix Health is a California-based biotechnology company pioneering the next evolution in skin health. We translate foundational insights in longevity science into transformative dermatological solutions. Grounded in a science-first approach, the company is developing an innovative pipeline of prescription therapeutics and professional skincare products. Re-Q Pro-Longevity Face Serum, the first product from Rapalogix’s professional skincare brand, Re-Q Health, is now available at select dermatology practices in the United States. Re-Q Pro-Longevity Face Serum is powered by RLX-201, Rapalogix’s proprietary pro-longevity molecule designed to reset and restore exhausted skin cells, extend their longevity, and deliver healthy and youthful skin over a lifetime.
For more information on Rapalogix Health, visit www.rapalogix.com or follow Rapalogix on LinkedIn and Instagram.
For more information on Re-Q Health, visit www.reqhealth.com or follow Re-Q Health on Instagram.
